CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Clinical Accelerator
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate
  • CRI Remembers Transformational Philanthropist, Chuck Feeney

    The Cancer Research Institute mourns the loss of Charles “Chuck” Feeney, an Irish American entrepreneur and philanthropist…
    October 11, 2023| Jill O'Donnell-Tormey, PhD
  • two male scientists in laboratories - one from the 1950s and one from the 2020s

    Celebrating Seven Decades of CRI Discovery in Cancer Immunotherapy

    On January 27, 1953, the Cancer Research Institute’s founders, Helen Coley Nauts and Oliver R. Grace Sr.,…
    January 27, 2023| Jill O'Donnell-Tormey, PhD
  • CRI Scientist’s “Rosetta Stone” Tech Unlocks New Era

    Dr. Alex Marson, a CRI-funded STAR, has developed a new genetic screening technology with potential to significantly…

    February 10, 2022| Jill O'Donnell-Tormey, PhD
  • A Special Message from the Cancer Research Institute

    CRI joins people within science, technology, engineering, and mathematics to pause our work as part of #ShutDownSTEM to…

    June 10, 2020| Jill O'Donnell-Tormey, PhD
  • A Special Message from the Cancer Research Institute

    CRI has taken steps to ensure the health and safety of our staff and community, and continue…

    March 18, 2020| Jill O'Donnell-Tormey, PhD
  • CRI Meets with the Vice President’s Staff on Moonshot

    CRI and Vice President Biden’s Moonshot Initiative collaborate for the advancement of cancer immunotherapy research.

    February 26, 2016| Jill O'Donnell-Tormey, PhD
  • William Coley and Cancer Immunotherapy Spotlighted on NPR

    The Cancer Research Institute received a very special holiday treat this morning, with a prominent mention at…

    December 28, 2015| Jill O'Donnell-Tormey, PhD
  • ASCO 2015: What to Watch in Immunotherapy

    Curious about what immunotherapy breakthroughs are coming at ASCO? Here’s a preview.

    May 28, 2015| Jill O'Donnell-Tormey, PhD
  • CRI’s Insights for ASCO 2015

    Our expert panel in cancer immunotherapy weighs in on what to look for at this year's meeting.

    May 18, 2015| Jill O'Donnell-Tormey, PhD

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Clinical Accelerator
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2026, Cancer Research Institute